Legal Representation
Attorney
Danielle Rivera
USPTO Deadlines
Next Deadline
7 days remaining
Published for Opposition
Due Date
December 25, 2025
Extension Available
Until January 25, 2026
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 23, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 23, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 8, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 8, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 8, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Classification
International Classes
005